Table 1. Characteristics of the samples used in the present study.
Code | Diagnosis | RIN | DV200 | Reads | % aligned | Genes with reads |
---|---|---|---|---|---|---|
OII-C | Oligodendroglioma, IDH-mutant, 1p/19q-codeleted Grade II | 2.30 | 44 | 40,109,782 | 90.44 | 33,371 |
OII-A | 2.40 | 49 | 41,087,894 | 87.68 | 30,906 | |
AIII-C | Astrocytoma, IDH-wildtype Grade III | 2.40 | 32 | 37,484,635 | 86.32 | 32,638 |
AIII-A | 2.40 | 28 | 45,693,652 | 86.31 | 32,639 | |
GS-C | Gliosarcoma, IDH-wildtype Grade IV | 2.00 | 53 | 44,422,490 | 91.43 | 30,970 |
GS-A | 1.90 | 71 | 40,142,882 | 92.84 | 32,394 | |
GB-C | Glioblastoma, IDH-wildtype Grade IV | 2.30 | 38 | 39,110,142 | 89.14 | 29,967 |
GB-A | 2.10 | 43 | 39,923,403 | 86.57 | 31,281 |
C = tumour core resection (TCR); A = cavitational ultrasonic surgical aspirate; RIN = RNA integrity number; DV200 = percentage of fragments >200 nt; Reads = numbers of paired reads; % aligned = % aligned reads to genome of reference.